Osteonate Tablets – osteoporosis in postmenopausal women & pagets disease.
Composition Each tablet contain: Alendronate 10 mg. Properties Alendronate binds to hydroxyapatite in bone, there by inhibiting osteoclast activity (the cells that resorb bone tissue). It therefore reduces the elevated rate of bone turnover observed in postmenopausal women. Alendronate, produces a progressive increase in bone mineral density, a reduction in the number of new asinal …
Osteonate Tablets – osteoporosis in postmenopausal women & pagets disease. Read More »